Oncodesign Precision Medicine S.A
ALOPM | Euronext Access Plus
Overview
Corporate Details
- ISIN(s):
- FR001400CM63
- LEI:
- 969500ZDX1IY47LDL876
- Country:
- France
- Address:
- 18 RUE JEAN MAZEN, 21000 DIJON
- Website:
- https://www.oncodesign.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Oncodesign Precision Medicine (OPM) is a biopharmaceutical company specializing in precision medicine. Its core mission is to discover and develop innovative therapeutic and diagnostic solutions for cancers that exhibit therapeutic resistance and metastasis. The company employs a patient-centric, translational approach, leveraging proprietary technology platforms to identify effective treatments and address the challenges of cancer evolution. OPM focuses on advancing its pipeline of drug candidates to provide new options for patients with resistant and metastatic cancers.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Oncodesign Precision Medicine S.A.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-11 18:00 |
Post-Annual General Meeting Information
Informations privilégiées / Autres communiqués
|
French | 466.5 KB | |
| 2025-05-06 18:00 |
Pre-Annual General Meeting Information
Informations privilégiées / Autres communiqués
|
French | 216.8 KB | |
| 2025-04-17 18:00 |
Capital/Financing Update
Inside Information / Other news releases
|
English | 341.8 KB | |
| 2025-04-17 18:00 |
Capital/Financing Update
Informations privilégiées / Autres communiqués
|
French | 331.1 KB | |
| 2025-04-03 18:00 |
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
|
French | 364.7 KB | |
| 2025-04-03 18:00 |
Earnings Release
Inside Information / News release on accounts, results
|
English | 379.5 KB | |
| 2025-03-24 18:11 |
Legal Proceedings Report
Informations privilégiées / Autres communiqués
|
French | 540.6 KB | |
| 2025-03-24 18:11 |
Legal Proceedings Report
Inside Information / Other news releases
|
English | 629.3 KB | |
| 2025-03-04 17:45 |
Board/Management Information
Nomination of Christophe Thurieau as an Independent Member of OPM Board of Dire…
|
French | 293.7 KB | |
| 2025-03-04 17:45 |
Board/Management Information
Nomination of Christophe Thurieau as an Independent Member of OPM Board of Dire…
|
English | 287.9 KB | |
| 2025-01-08 18:00 |
Capital/Financing Update
Informations privilégiées / Autres communiqués
|
French | 604.4 KB | |
| 2024-12-20 08:00 |
Regulatory News Service
Inside Information / Other news releases
|
English | 296.9 KB | |
| 2024-12-20 08:00 |
M&A Activity
Informations privilégiées / Autres communiqués
|
French | 284.3 KB | |
| 2024-10-22 18:00 |
Regulatory News Service
Inside Information / Other news releases
|
English | 310.0 KB | |
| 2024-10-22 18:00 |
Regulatory News Service
Informations privilégiées / Autres communiqués
|
French | 312.5 KB |
Automate Your Workflow. Get a real-time feed of all Oncodesign Precision Medicine S.A filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Oncodesign Precision Medicine S.A via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
